← All trials
NCT00039741
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2002
- Primary completion
- Aug 1, 2009
- Completion date
- Mar 1, 2010
- First posted
- —
- Last posted
- —
- Enrollment
- 266
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- National Institute of Allergy and Infectious Diseases (NIAID)Lead sponsor
- Duke UniversityStudy chair
- PENTA FoundationCollaborator
- University of WashingtonStudy chair
- National Institutes of Health (NIH)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.